Your cart is empty.
Zurich, Switzerland, September 12, 2007 – Tecan announced that it will present at the 200 UBS Global Life Sciences Conference on Monday, September 24, 2007 at 1:30 p.m. (EDT) at the Grand Hyatt New York, New York, NY.
Thomas Bachmann, Chief Executive Officer of Tecan, will give an overview of Tecan and discuss its market and expectations for the future.
Mr. Bachmann’s presentation will also be relayed by live audio web cast which interested parties may access via Tecan’s corporate home page at www.tecan.com. A link to the web cast will be provided immediately prior to the event. An audio archive of the presentation will remain available on the company’s website until October 27, 2007.
Tecan (www.tecan.com) is a leading global supplier of solutions for the biopharma, forensic and diagnostic industries. The company is a leader in the development, production and distribution of advanced automation and detection solutions for the world’s leading life science laboratories. Through its REMP subsidiary (www.remp.com), Tecan is the premier supplier of large-scale automated laboratory storage and logistics systems. Its customers include pharmaceutical and biotechnology companies, university research departments and diagnostic laboratories. Founded in Switzerland in 1980, the company has over 1100 employees, owns production, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2006, Tecan achieved sales of CHF 405.9 million (USD 324.7 million; EUR 258.6 million). Shares of the Tecan Group are traded on the SWX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Sec. no.: 1210019).
For further information please contact:
Tecan Group Ltd.
Head of Corporate & Business Development